Kumar Patel, MD
Allergy & Immunology · Tarentum, PANPI 1720198393
Payments from drug & device makers
Across 1,357 payments — averaging $91.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$92K
- Novartis$8K
- AstraZeneca$7K
- Optinose US, Inc.$4K
- Sanofi$3K
- CSL Behring$2K
- plus $9K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 381 | $91,918 |
| Novartis | 69 | $7,789 |
| AstraZeneca | 234 | $6,519 |
| Optinose US, Inc. | 37 | $4,387 |
| Sanofi | 78 | $2,509 |
| CSL Behring | 91 | $1,826 |
| Regeneron Healthcare Solutions, Inc. | 89 | $1,690 |
| Amgen(2 entities) | 63 | $1,194 |
| Teva Pharmaceuticals USA, Inc. | 73 | $801 |
| Genentech USA, Inc. | 35 | $755 |
| Biocryst US Sales Co., LLC | 50 | $693 |
| ARS Pharmaceuticals Operations, Inc. | 26 | $566 |
| Kaleo, Inc. | 31 | $525 |
| Boehringer Ingelheim | 33 | $498 |
| Pfizer | 21 | $405 |
| Pharming Healthcare, Inc. | 5 | $375 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $358 |
| Grifols USA, LLC | 2 | $282 |
| Incyte Corporation | 4 | $164 |
| Blueprint Medicines Corporation | 2 | $151 |
| Sanofi-aventis U.S. LLC | 2 | $130 |
| Aimmune Therapeutics, Inc. | 4 | $95 |
| Merck | 4 | $71 |
| Cycle Pharmaceuticals Inc | 3 | $65 |
| Alk-abello, Inc | 2 | $37 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Phadia US Inc. | 1 | $16 |
| Circassia Inc. | 1 | $15 |
How this compares
$123,909 in reported general payments places this provider in the 90th percentile of 175 allergy & immunology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Tarentum
- Drew WeissmanPhiladelphia$15.3M
- Timothy CraigHershey$2M
- Eric SchenkelBethlehem$845K
- Sergei BelenkyPittsburgh$775K
- Sandra GawchikUpland$390K
- Anthony RooklinGlen Mills$319K
- Corinna BowserNarberth$229K
- Thomas KleinHavertown$222K
- Rahul DattaPhiladelphia$198K
- Shailen ShahCollegeville$183K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.